Literature DB >> 34553960

Oculomotor inhibition and location priming in schizophrenia.

Sonia Bansal1, Nicholas Gaspelin2, Benjamin M Robinson1, Britta Hahn1, Steven J Luck3, James M Gold1.   

Abstract

Schizophrenia is widely thought to involve elevated distractibility, which may reflect a general impairment in top-down inhibitory processes. Schizophrenia also appears to involve increased priming of previously performed actions. Here, we used a highly refined eye-tracking paradigm that makes it possible to concurrently assess distractibility, inhibition, and priming. In both healthy control subjects (HCS, N = 41) and people with schizophrenia (PSZ, N = 46), we found that initial saccades were actually less likely to be directed toward a salient "singleton" distractor than toward less salient distractors, reflecting top-down suppression of the singleton. Remarkably, this oculomotor suppression effect was as strong or stronger in PSZ than in HCS, indicating intact inhibitory control. In addition, saccades were frequently directed to the location of the previous-trial target in both groups, but this priming effect was much stronger in PSZ than in HCS. Indeed, PSZ directed gaze toward the location of the previous-trial target as often as they directed gaze to the location of the current-trial target. These results demonstrate that-at least in the context of visual search-PSZ are no more distractable than HCS and are fully capable of inhibiting salient-but-irrelevant stimuli. However, PSZ do exhibit exaggerated priming, focusing on recently attended locations even when this is not beneficial for goal attainment. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Entities:  

Mesh:

Year:  2021        PMID: 34553960      PMCID: PMC8480515          DOI: 10.1037/abn0000683

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  70 in total

1.  Understanding priming of color-singleton search: roles of attention at encoding and "retrieval".

Authors:  B A Goolsby; S Suzuki
Journal:  Percept Psychophys       Date:  2001-08

2.  Toward the neural mechanisms of reduced working memory capacity in schizophrenia.

Authors:  Carly J Leonard; Sam T Kaiser; Benjamin M Robinson; Emily S Kappenman; Britta Hahn; James M Gold; Steven J Luck
Journal:  Cereb Cortex       Date:  2012-06-01       Impact factor: 5.357

3.  Impaired control of visual attention in schizophrenia.

Authors:  Rebecca L Fuller; Steven J Luck; Elsie L Braun; Benjamin M Robinson; Robert P McMahon; James M Gold
Journal:  J Abnorm Psychol       Date:  2006-05

4.  Introspective awareness of oculomotor attentional capture.

Authors:  Owen J Adams; Nicholas Gaspelin
Journal:  J Exp Psychol Hum Percept Perform       Date:  2021-01-25       Impact factor: 3.332

5.  Learned and cued distractor rejection for multiple features in visual search.

Authors:  Brad T Stilwell; Shaun P Vecera
Journal:  Atten Percept Psychophys       Date:  2019-02       Impact factor: 2.199

6.  Selective Attention, Working Memory, and Executive Function as Potential Independent Sources of Cognitive Dysfunction in Schizophrenia.

Authors:  James M Gold; Benjamin Robinson; Carly J Leonard; Britta Hahn; Shuo Chen; Robert P McMahon; Steven J Luck
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

7.  Evidence of reduced 'cognitive inhibition' in schizophrenia.

Authors:  A Beech; T Powell; J McWilliam; G Claridge
Journal:  Br J Clin Psychol       Date:  1989-05

8.  Prior target locations attract overt attention during search.

Authors:  Travis N Talcott; Nicholas Gaspelin
Journal:  Cognition       Date:  2020-05-05

Review 9.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

10.  Impaired contingent attentional capture predicts reduced working memory capacity in schizophrenia.

Authors:  Jutta S Mayer; Keisuke Fukuda; Edward K Vogel; Sohee Park
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.